Chennai Meenakshi Multispeciality Hospital Ltd
Incorporated in 1979, Chennai Meenakshi Multispecialty Hospital Ltd is in the business of providing healthcare services[1]
- Market Cap ₹ 35.9 Cr.
- Current Price ₹ 48.0
- High / Low ₹ 59.9 / 28.3
- Stock P/E
- Book Value ₹ -3.44
- Dividend Yield 0.00 %
- ROCE -5.14 %
- ROE %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 21.4% over last quarter.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.91% over past five years.
- Earnings include an other income of Rs.1.29 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.59 | 18.71 | 20.36 | 18.79 | 23.11 | 22.00 | 25.33 | 19.15 | 30.86 | 38.19 | 37.38 | 33.76 | 36.12 | |
| 15.21 | 16.57 | 17.34 | 17.49 | 19.30 | 19.89 | 22.88 | 18.51 | 25.12 | 35.16 | 35.48 | 33.96 | 36.37 | |
| Operating Profit | 2.38 | 2.14 | 3.02 | 1.30 | 3.81 | 2.11 | 2.45 | 0.64 | 5.74 | 3.03 | 1.90 | -0.20 | -0.25 |
| OPM % | 13.53% | 11.44% | 14.83% | 6.92% | 16.49% | 9.59% | 9.67% | 3.34% | 18.60% | 7.93% | 5.08% | -0.59% | -0.69% |
| 0.30 | -0.54 | 0.14 | 0.13 | 0.22 | 0.50 | 0.73 | 0.52 | 0.39 | 0.32 | 0.28 | 0.85 | 1.29 | |
| Interest | 1.39 | 1.38 | 1.34 | 1.36 | 1.39 | 1.36 | 1.39 | 1.14 | 0.98 | 0.89 | 0.92 | 0.91 | 0.90 |
| Depreciation | 0.81 | 1.19 | 1.16 | 1.12 | 1.15 | 1.20 | 1.24 | 1.27 | 1.17 | 1.18 | 1.16 | 1.16 | 1.11 |
| Profit before tax | 0.48 | -0.97 | 0.66 | -1.05 | 1.49 | 0.05 | 0.55 | -1.25 | 3.98 | 1.28 | 0.10 | -1.42 | -0.97 |
| Tax % | 8.33% | 0.00% | 0.00% | 0.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.47% | 530.00% | -3.52% | |
| 0.45 | -0.97 | 0.65 | -1.06 | 1.50 | 0.05 | 0.55 | -1.25 | 3.98 | 0.89 | -0.43 | -1.37 | -0.91 | |
| EPS in Rs | 0.60 | -1.30 | 0.87 | -1.42 | 2.01 | 0.07 | 0.74 | -1.67 | 5.33 | 1.19 | -0.58 | -1.83 | -1.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 3% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 38% |
| 3 Years: | 28% |
| 1 Year: | 23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| Reserves | -11.97 | -12.94 | -12.29 | -13.21 | -11.64 | -11.60 | -11.03 | -12.24 | -8.25 | -7.35 | -7.80 | -9.36 | -10.04 |
| 12.74 | 12.13 | 12.20 | 12.24 | 12.26 | 12.21 | 11.48 | 11.48 | 10.63 | 10.63 | 11.42 | 10.63 | 10.63 | |
| 10.98 | 12.05 | 11.09 | 11.84 | 11.26 | 11.11 | 11.53 | 12.49 | 11.54 | 11.35 | 11.72 | 13.76 | 14.19 | |
| Total Liabilities | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 22.25 |
| 15.11 | 15.27 | 14.51 | 14.01 | 14.53 | 14.07 | 13.86 | 12.87 | 14.08 | 13.94 | 14.66 | 13.77 | 13.29 | |
| CWIP | 0.47 | 0.01 | 0.07 | 0.02 | 0.02 | 0.12 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 3.64 | 3.43 | 3.89 | 4.31 | 4.80 | 5.00 | 5.47 | 6.21 | 7.31 | 8.16 | 8.15 | 8.73 | 8.96 | |
| Total Assets | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 22.25 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.32 | 4.00 | 1.74 | 2.61 | 2.20 | 2.31 | 2.99 | 3.30 | 3.97 | 2.95 | 2.09 | 2.17 | |
| -2.30 | -1.78 | -0.23 | -0.47 | -1.61 | -0.81 | -0.95 | -0.14 | -2.21 | -1.91 | -1.86 | -0.75 | |
| -1.91 | -2.00 | -1.41 | -1.32 | -1.37 | -1.41 | -2.12 | -0.98 | -1.62 | -0.75 | 0.03 | -1.56 | |
| Net Cash Flow | 0.11 | 0.22 | 0.10 | 0.82 | -0.77 | 0.10 | -0.08 | 2.18 | 0.14 | 0.29 | 0.26 | -0.14 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11.83 | 10.53 | 9.68 | 11.27 | 12.16 | 13.77 | 15.27 | 15.06 | 10.88 | 11.28 | 6.25 | 8.65 |
| Inventory Days | 36.25 | 32.03 | 46.85 | 46.28 | 50.71 | 40.84 | 39.46 | 45.33 | 20.98 | 22.71 | 21.50 | 24.49 |
| Days Payable | 112.88 | 108.01 | 80.41 | 87.33 | 88.28 | 80.39 | 66.15 | 117.24 | 105.93 | 88.74 | 51.61 | 89.40 |
| Cash Conversion Cycle | -64.80 | -65.45 | -23.88 | -29.79 | -25.40 | -25.78 | -11.42 | -56.85 | -74.08 | -54.75 | -23.85 | -56.26 |
| Working Capital Days | -171.61 | -185.72 | -143.60 | -178.91 | -123.83 | -125.76 | -95.83 | -170.78 | -81.73 | -67.28 | -74.02 | -98.71 |
| ROCE % | 22.61% | 14.36% | 28.49% | 4.47% | 39.48% | 17.44% | 24.25% | -1.50% | 59.90% | 21.36% | 11.08% | -5.14% |
Documents
Announcements
-
Announcement Under Regulation 30 (LODR)-Updates (Reconstituted The Composition Of Committees)
1d - Board reconstituted Audit, Nomination & Remuneration, Stakeholders Relationship Committees on Nov 13, 2025.
-
Results-Financial Results For September 30, 2025.
1d - Approved unaudited Q2/H1 results ended 30 Sep 2025; total income Rs1872.74 lakh; H1 loss Rs62.74 lakh.
-
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 13-11-2025
1d - Unaudited results: Q2 revenue Rs980.85L, Q2 profit Rs14.96L, H1 loss Rs59.15L; shareholders' deficit Rs257.18L.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 4 Nov
-
Board Meeting Intimation for 1. Review On Performance Of The Company
2. Approval Of Unaudited Statement Of Financial Results For The Quarter And Half Year Ended 30Th September,2025.
3. To Record The Minutes Of Last Board Meeting
3 Nov - Board meeting on Nov 13, 2025 to approve unaudited Q2/H1 results; trading window closed Oct 1 until 48 hours post-declaration.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
CMMHL is a multispeciality hospital that provides multiple health treatments and health care services. Specialists from various fields visit the hospital at shorter notice, to provide medical treatment to the patients